Global Metabolism Drugs Market 2016 Industry Trends, Sales, Production, Supply, Demand, Analysis & Forecast to 2021
- QYR558200
- 143 Pages
- April 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The metabolism drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, production revenue, cost, sales revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The metabolism drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 211 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview 1
1.1 Definition and Specifications of Metabolism Drugs 1
1.1.1 Definition of Metabolism Drugs 1
1.1.2 Specifications of Metabolism Drugs 2
1.2 Classification of Metabolism Drugs 2
1.2.1 Glycogen Metabolism Disease Drug 3
1.2.2 Lipid Metabolism Disease Drug 4
1.2.3 Amino Acid Metabolism Drug 4
1.3 Applications of Metabolism Drugs 5
1.3.1 Hospital 6
1.3.2 Retail Pharmacy 7
1.4 Industry Chain Structure of Metabolism Drugs 7
1.5 Industry Overview and Major Regions Status of Metabolism Drugs 8
1.5.1 Industry Overview of Metabolism Drugs 8
1.5.2 Global Major Regions Status of Metabolism Drugs 9
1.6 Industry Policy Analysis of Metabolism Drugs 9
1.7 Industry News Analysis of Metabolism Drugs 10
2 Manufacturing Cost Structure Analysis of Metabolism Drugs 12
2.1 Raw Material Suppliers and Price Analysis of Metabolism Drugs 12
2.2 Equipment Suppliers Analysis of Metabolism Drugs 13
2.3 Labor Cost Analysis of Metabolism Drugs 14
2.4 Manufacturing Cost Structure Analysis of Metabolism Drugs 21
2.5 Other Costs Analysis of Metabolism Drugs 22
2.6 Manufacturing Cost Structure Analysis of Metabolism Drugs 27
2.7 Manufacturing Process Analysis of Metabolism Drugs 28
3 Technical Data and Manufacturing Plants Analysis of Metabolism Drugs 30
3.1 Capacity and Commercial Production Date of Global Metabolism Drugs Major Manufacturers in 2015 30
3.2 Manufacturing Plants Distribution of Global Metabolism Drugs Major Manufacturers in 2015 30
3.3 R&D Status and Technology Source of Global Metabolism Drugs Major Manufacturers in 2015 31
3.4 Global Metabolism Drugs Major Manufacturers Investment (by the end 2015) 31
3.5 Global Metabolism Drugs Major research progress (by the end 2015) 32
4 Production Analysis of Metabolism Drugs by Region, Type, and Application 35
4.1 Global Production Revenue of Metabolism Drugs by Region 2011-2016 35
4.2 Global Production Revenue of Metabolism Drugs by Type 2011-2016 39
4.3 Global Production Revenue of Metabolism Drugs by Application 2011-2016 43
4.4 Global Different Product Production Revenue of Metabolism Drugs by Region 2011-2016 46
4.5 USA Cost, Revenue, Supply, Import, Export and Consumption of Metabolism Drugs 2011-2016 47
4.6 Europe Cost, Revenue, Supply, Import, Export and Consumption of Metabolism Drugs 2011-2016 48
4.7 Japan Cost, Revenue, Supply, Import, Export and Consumption of Metabolism Drugs 2011-2016 48
4.8 Asia(EX.Japan) Cost, Revenue, Supply, Import, Export and Consumption of Metabolism Drugs 2011-2016 49
5 Consumption Volume and Consumption Value Analysis of Metabolism Drugs by Region 50
5.1 Global Consumption Value of Metabolism Drugs by Region 2011-2016 50
5.2 Global Glycogen Metabolism Disease Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 54
5.3 Global Lipid Metabolism Disease Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 58
5.4 Global Amino Acid Metabolism Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 62
6 Analysis of Metabolism Drugs Production Revenue, Sales Revenue and Market Status 2011-2016 66
6.1 Production Revenue of Metabolism Drugs 2011-2016 66
6.2 Production Revenue Market Share Analysis of Metabolism Drugs 2011-2016 68
6.3 Sales Overview of Metabolism Drugs 2011-2016 71
6.4 Supply Revenue, Sales Revenue and Gap of Metabolism Drugs 2011-2016 71
6.5 Gross Margin of Metabolism Drugs 2011-2016 71
7 Analysis of Metabolism Drugs Industry Key Manufacturers 74
7.1 Merck Sharp & Dohme 74
7.1.1 Company Profile 74
7.1.2 Product Information 75
7.1.3 Revenue and Gross Margin 76
7.2 Novartis 78
7.2.1 Company Profile 78
7.2.2 Product Information 79
7.2.3 Revenue and Gross Margin 80
7.3 Takeda Pharmaceutical 81
7.3.1 Company Profile 81
7.3.2 Product Information 82
7.3.3 Revenue and Gross Margin 84
7.4 AstraZeneca 85
7.4.1 Company Profile 85
7.4.2 Product Information 86
7.4.3 Revenue and Gross Margin 88
7.5 Boehringer Ingelheim 90
7.5.1 Company Profile 90
7.5.2 Product Information 91
7.5.3 Revenue and Gross Margin 92
7.6 KOWA 94
7.6.1 Company Profile 94
7.6.2 Product Information 94
7.6.3 Revenue and Gross Margin 95
7.7 Kythera 96
7.7.1 Company Profile 96
7.7.2 Product Picture and Specifications 97
7.7.3 Revenue and Gross Margin 97
7.8 Fuji yakuhin 99
7.8.1 Company Profile 99
7.8.2 Product Information 99
7.8.3 Revenue and Gross Margin 100
7.9 LG Life Sciences 101
7.9.1 Company Profile 101
7.9.2 Product Information 102
7.9.3 Revenue and Gross Margin 102
7.10 Mitsubishi Tanabe Pharma 104
7.10.1 Company Profile 104
7.10.2 Product Information 105
7.10.3 Revenue and Gross Margin 105
8 Supply and Sales, Gross Margin Analysis 107
8.1 Analysis of Gross Margin, Supply and Sales Revenue 107
8.1.1 Gross Margin Analysis 107
8.1.2 Production, Sales Analysis 107
8.2 Gross Margin Analysis 108
8.3 Global Different Product Production Revenue Market Share of Metabolism Drugs by Region 2011-2016 109
8.4 Sales Revenue Analysis of Different Metabolism Drugs Product Types 110
8.5 Gross Margin Analysis of Different Metabolism Drugs Applications 110
9 Marketing Trader or Distributor Analysis of Metabolism Drugs 111
9.1 Marketing Channels Status of Metabolism Drugs 111
9.2 Traders or Distributors with Contact Information of Metabolism Drugs by Regions 112
9.3 Regional Import, Export Analysis of Metabolism Drugs 113
10 Development Trend of Metabolism Drugs Industry 2016-2021 114
10.1 Sales Overview of Metabolism Drugs2016-2021 114
10.2 Global and Major Manufacturers Sales of Metabolism Drugs2016-2021 115
10.3 Global and Sales of Metabolism Drugs by Regions 2016-2021 116
11 Industry Chain Suppliers of Metabolism Drugs with Contact Information 118
11.1 Raw Materials Suppliers of Metabolism Drugs with Contact Information 118
11.2 Manufacturing Equipment Suppliers of Metabolism Drugs with Contact Information 120
11.3 Key Consumers of Metabolism Drugs with Contact Information 122
11.4 Supply Chain Relationship Analysis of Metabolism Drugs 124
12 New Project SWOT Analysis of Metabolism Drugs 125
13 Conclusion of the Global Metabolism Drugs Industry Report 2016 126
Figure Picture of Metabolism Drugs 1
Figure Comparison of Main Models from Metabolism Drugs Major Manufacturers 2
Table Different Types of Metabolism Drugs 2
Figure Global Production Market Share of Metabolism Drugs by Type in 2015 3
Figure Glycogen Metabolism Disease Drug Picture 3
Figure Lipid Metabolism Disease Drug Picture 4
Figure Amino Acid Metabolism Drug Picture 5
Table Applications of Metabolism Drugs 5
Figure 2015 Global Metabolism Drugs Major Applications Sales Share 6
Figure Hospital Examples 6
Figure Retail Pharmacy Examples 7
Figure Industry Chain Structure of Metabolism Drugs 7
Table Global Metabolism Drugs Major Manufacturers 8
Figure Global Major Regions Metabolism Drugs Development Status in 2015 9
Table Industry Policy of Metabolism Drugs 9
Table Industry News List of Metabolism Drugs 10
Table Major Raw Materials Analysis of Metabolism Drugs 12
Table Key Equipment Analysis of Metabolism Drugs 13
Figure Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 15
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2014 16
Figure Average Manufacturing Cost Index in 2004 16
Figure Average Manufacturing Cost Index in 2014 17
Figure United States Average Hourly Wages (USD/H) 2010-2015 17
Table United States Average Hourly Wages (USD/H) in 2015 18
Figure Germany Labor Costs 2013-2015 18
Figure France Labor Costs 2013-2015 19
France Average Nominal Monthly Wages 2006-2014 19
Figure United Kingdom Labor Costs 2013-2015 20
Figure Netherlands Labor Costs 2013-2015 20
Figure China Labor Costs 2013-2016 21
Figure China Average Yearly Wages2006-2014 (CNY/Year) 21
Figure Annual Depreciation Rate of Equipment in 2010-2015 22
Table 2014 Global Electricity Price of Resident and Industry (USD/Kw?h) by Country 22
Table US Average Price of Electricity to Ultimate Customers by End-Use Sector, by State, September 2015 and 2014 (Cents per KWh) 23
Table 2012- 2014 EU Electricity Prices (EUR per kWh) 26
Table Manufacturing Cost Structure Analysis of Metabolism Drugs in 2015 27
Figure Manufacturing Process Analysis of Metabolism Drugs 28
Figure Metabolism Drugs Marketing Process 29
Table Revenue (M USD) and Commercial Date of Global Metabolism Drugs Major Manufacturers in 2015 30
Table Manufacturing Plants Distribution of Global Metabolism Drugs Major Manufacturers in 2015 30
Table R&D Status and Technology Source of Global Metabolism Drugs Major Manufacturers in 2015 31
Table Global Metabolism Drugs Major Manufacturers Investment (by the end 2015) 31
Table Some DPP-IV inhibitor drug research progress 32
Table Some SGLT2 inhibitors drug research progress 32
Table New Metabolic Drugs Launched from 2007 to 2013 33
Table Acquisition Information of Partial Companies 33
Table Global Production Revenue of Metabolism Drugs by Region 2011-2016 (M USD) 35
Table Global Production Revenue Market Share of Metabolism Drugs by Region 2011-2016 35
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2011 36
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2012 36
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2013 37
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2014 37
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2015 38
Figure Global Production Revenue Market Share of Metabolism Drugs by Region in 2016 38
Table Global Production Revenue of Metabolism Drugs by Type 2011-2016 (M USD) 39
Table Global Production Revenue Market Share of Metabolism Drugs by Type 2011-2016 39
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2011 40
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2012 40
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2013 41
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2014 41
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2015 42
Figure Global Production Revenue Market Share of Metabolism Drugs by Type in 2016 42
Table Global Production Revenue of Metabolism Drugs by Application 2011-2016 (M USD) 43
Table Global Production Revenue Market Share of Metabolism Drugs by Application 2011-2016 43
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2011 43
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2012 44
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2013 44
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2014 45
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2015 45
Figure Global Production Revenue Market Share of Metabolism Drugs by Application in 2016 46
Figure Glycogen Metabolism Disease Drug Production Revenue of Metabolism Drugs by Region 2011-2016 46
Figure Lipid Metabolism Disease Drug Production Revenue of Metabolism Drugs by Region 2011-2016 46
Figure Amino Acid Metabolism Drug Production Revenue of Metabolism Drugs by Region 2011-2016 47
Table USA Revenue (M USD), Cost (M USD), and Gross Margin of Metabolism Drugs 2011-2016 47
Table USA Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Metabolism Drugs 2011-2016 (M USD) 47
Table Europe Revenue (M USD), Cost (M USD), and Gross Margin of Metabolism Drugs 2011-2016 48
Table Europe Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Metabolism Drugs 2011-2016 (M USD) 48
Table Japan Revenue (M USD), Cost (M USD), and Gross Margin of Metabolism Drugs 2011-2016 48
Table Japan Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Metabolism Drugs 2011-2016 (M USD) 49
Table Asia(EX.Japan) Revenue (M USD), Cost (M USD), and Gross Margin of Metabolism Drugs 2011-2016 49
Table Asia(EX.Japan) Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Metabolism Drugs 2011-2016 (M USD) 49
Table Global Consumption Value of Metabolism Drugs by Region 2011-2016 (M USD) 50
Table Global Consumption Value Market Share of Metabolism Drugs by Region 2011-2016 50
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2011 51
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2012 51
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2013 52
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2014 52
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2015 53
Figure Global Consumption Value Market Share of Metabolism Drugs by Region in 2016 53
Table Global Glycogen Metabolism Disease Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 (M USD) 54
Table Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region 2011-2016 54
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2011 55
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2012 55
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2013 56
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2014 56
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2015 57
Figure Global Glycogen Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2016 57
Table Global Lipid Metabolism Disease Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 (M USD) 58
Table Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region 2011-2016 58
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2011 59
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2012 59
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2013 60
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2014 60
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2015 61
Figure Global Lipid Metabolism Disease Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2016 61
Table Global Amino Acid Metabolism Drug Sales Revenue of Metabolism Drugs by Region 2011-2016 (M USD) 62
Table Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region 2011-2016 62
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2011 63
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2012 63
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2013 64
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2014 64
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2015 65
Figure Global Amino Acid Metabolism Drug Sales Revenue Market Share of Metabolism Drugs by Region in 2016 65
Table Global and Major Manufacturers Production Revenue Metabolism Drugs 2011-2016 (M USD) 66
Table Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers 2011-2016 66
Figure Global Revenue (M USD) and Growth Rate of Metabolism Drugs 2011-2016 67
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2011 68
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2012 68
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2013 69
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2014 69
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2015 70
Figure Global Production Revenue Market Share of Major Metabolism Drugs Manufacturers in 2016 70
Figure Global Sales Revenue (M USD) and Growth Rate of Metabolism Drugs 2011-2016 71
Table Global Supply Revenue, Sales Revenue and Gap of Metabolism Drugs 2011-2016 (M USD) 71
Table Gross Margin of Global Metabolism Drugs Major Manufacturers 2011-2016 71
Figure Gross Margin of Global Metabolism Drugs Major Manufacturers in 2015 72
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Metabolism Drugs 2011-2016 72
Table Merck Sharp & Dohme Company Profile 74
Figure Januvia Product Picture of Merck Sharp & Dohme 75
Figure Janumet Product Picture of Merck Sharp & Dohme 76
Figure Janumet XR Product Picture of Merck Sharp & Dohme 76
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Roche 2011-2016 76
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Merck Sharp & Dohme 2011-2016 77
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Merck Sharp & Dohme 2011-2016 77
Table Novartis Company Profile 78
Figure Metabolism Drugs Product Picture of Novartis 79
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Roche 2011-2016 80
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Novartis 2011-2016 80
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Novartis 2011-2016 81
Table Takeda Pharmaceutical Company Profile 81
Figure Nesina Product Picture of Takeda Pharmaceutical 82
Figure Kazano Product Picture of Takeda Pharmaceutical 83
Figure Febuxostat Tablets Product Picture of Takeda Pharmaceutical 83
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Takeda Pharmaceutical 2011-2016 84
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Takeda Pharmaceutical 2011-2016 84
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Takeda Pharmaceutical 2011-2016 85
Table AstraZeneca Company Profile 85
Figure Onglyza Product Picture of AstraZeneca 86
Figure Kombiglyze XR Product Picture of AstraZeneca 87
Figure Lesinurad Product Picture of AstraZeneca 88
Table Metabolism Drugs Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016 88
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of AstraZeneca 2011-2016 89
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of AstraZeneca 2011-2016 89
Table Boehringer Ingelheim Company Profile 90
Figure Tradjenta Product Picture of Boehringer Ingelheim 91
Figure Glyxambi Product Picture of Boehringer Ingelheim 92
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016 92
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Boehringer Ingelheim 2011-2016 93
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Boehringer Ingelheim 2011-2016 93
Table KOWA Company Profile 94
Figure Suiny Picture of KOWA 94
Table Metabolism Drugs Revenue (M USD) and Gross Margin of KOWA 2011-2016 95
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of KOWA 2011-2016 95
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of KOWA 2011-2016 96
Table Kythera Information List 96
Figure Kybella Picture of Kythera 97
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Kythera 2011-2016 97
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Kythera 2011-2016 98
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Kythera 2011-2016 98
Table Fuji yakuhin Information List 99
Figure Topiroxostat Picture of Fuji yakuhin 99
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Fuji yakuhin 2011-2016 100
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Fuji yakuhin 2011-2016 100
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Fuji yakuhin 2011-2016 101
Table LG Life Sciences Company Profile 101
Figure Zemiglo Product Picture of LG Life Sciences 102
Table Metabolism Drugs Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016 102
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of LG Life Sciences 2011-2016 103
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of LG Life Sciences 2011-2016 103
Table Mitsubishi Tanabe Pharma Company Profile 104
Figure Zafatek Product Picture of Mitsubishi Tanabe Pharma 105
Table Metabolism Drugs Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2011-2016 105
Figure Metabolism Drugs Revenue (M USD) and Growth Rate of Mitsubishi Tanabe Pharma 2011-2016 106
Figure Metabolism Drugs Revenue (M USD) and Global Market Share of Mitsubishi Tanabe Pharma 2011-2016 106
Table Gross Margin of Global Metabolism Drugs Major Manufacturers 2011-2016 107
Table USA Production Revenue and Sales Revenue Analysis (M USD) 107
Table Europe Production Revenue and Sales Revenue Analysis (M USD) 108
Table Japan Production Revenue and Sales Revenue Analysis (M USD) 108
Table Asia(EX. Japan) Production Revenue and Sales Revenue Analysis (M USD) 108
Table Gross Margin of Global Regions 2011-2016 108
Figure Glycogen Metabolism Disease Drug Production Revenue Market Share of Metabolism Drugs by Region 2011-2016 109
Figure Lipid Metabolism Disease Drug Production Revenue Market Share of Metabolism Drugs by Region 2011-2016 109
Figure Amino Acid Metabolism Drug Production Revenue Market Share of Metabolism Drugs by Region 2011-2016 109
Table Sales Revenue of Different Metabolism Drugs Product Types (M USD) 110
Table Gross Margin of Different Metabolism Drugs Applications 2011-2016 110
Figure Marketing Channels of Metabolism Drugs 111
Table Traders or Distributors with Contact Information of Metabolism Drugs by Regions 112
Table Regional Import, Export of Metabolism Drugs (M USD) 113
Table Global Sales (M USD), Gross Margin and Growth Rate of Metabolism Drugs 2016-2021 114
Figure Global Sales (M USD) and Growth Rate of Metabolism Drugs 2016-2021 114
Figure Global Sales Market Share of Major Metabolism Drugs Manufacturers in 2016 115
Figure Global Sales Market Share of Major Metabolism Drugs Manufacturers in 2021 116
Table Global Sales of Metabolism Drugs by Regions 2016-2021 (M USD) 116
Table Global Sales Market Share of Metabolism Drugs by Regions 2016-2021 116
Figure Global Sales (M USD) of Metabolism Drugs by Regions in 2016 117
Figure Global Sales (M USD) of Metabolism Drugs by Regions in 2021 117
Table Major Raw Materials Analysis of Metabolism Drugs with Contact Information 118
Table Manufacturing Equipment Suppliers of Metabolism Drugs with Contact Information 120
Table Key Consumers of Metabolism Drugs with Contact Information 122
Figure Supply Chain Relationship Analysis of Metabolism Drugs 124
Table New Project SWOT Analysis of Metabolism Drugs 125
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
